NCT04184856

Brief Summary

People who suffer from binge eating disorder experience recurrent episodes of binge eating.During these episodes, they consume an unusually large amount of food in a short amount of time and experience loss of control over eating. However, why such binge eating episodes occur is still largely unknown. This makes it difficult to develop targeted treatments. In this project, the experimenters are investigating the brain mechanisms that give rise to the disorder. They hypothesize that the binge eating episodes are due to an increased variability in reward processing, which they will assess repeatedly over days. They will test this hypothesis using mathematical models based on behavioural and MRI measurements that are related to the processing of rewards.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2019

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 4, 2019

Completed
2 days until next milestone

Study Start

First participant enrolled

December 6, 2019

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2021

Completed
Last Updated

August 11, 2021

Status Verified

April 1, 2021

Enrollment Period

1.5 years

First QC Date

October 29, 2019

Last Update Submit

August 10, 2021

Conditions

Keywords

reward sensitivityneuroimagingvariabilityecological momentary assessment (EMA)

Outcome Measures

Primary Outcomes (3)

  • Variability in blood-oxygen-level dependent (BOLD) signalling in the NAcc during effort allocation task

    Variability of BOLD signal in the nucleus accumbens (NAcc) over time and between trials while performing an effort allocation task. The signal is measured through functional magnetic resonance imaging (fMRI) and variability is determined through model residuals.

    100 min

  • Trial-to-trial variability in reward seeking in an effort allocation task

    Variability of performance is an intra-individual measure, that is defined by the residuals of a linear mixed effects model of trial-to-trial performance on the effort allocation task.

    40 min

  • Variability in BOLD signalling in the NAcc for food-cue reactivity

    Variability of BOLD signal in the NAcc between blocks of food pictures. The signal is measured through fMRI and variability is determined through model residuals.

    15

Secondary Outcomes (1)

  • Variability in BOLD signalling in the NAcc during non-food-cue reactivity

    5

Study Arms (3)

Binge eating disorder (BED) patients

Individuals with BED diagnosis.

Diagnostic Test: fMRI

non-BED controls

Individuals that do not experience binges

Diagnostic Test: fMRI

subsyndromal BED controls

individuals that experience binges but do not fulfill the requirements for BED diagnosis.

Diagnostic Test: fMRI

Interventions

fMRIDIAGNOSTIC_TEST

(Imaging while) performing reward related tasks.

Binge eating disorder (BED) patientsnon-BED controlssubsyndromal BED controls

Eligibility Criteria

Age18 Years - 69 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The control group will consist of residents of the general area around Tübingen, Germany. BED patients will be recruited mainly from the outpatient clinic of the Department of Clinical Psychology of Tübingen, Germany.

You may qualify if:

  • Binge eating disorder diagnosis
  • Subsyndromal binge eating (control)

You may not qualify if:

  • high risk of suicide
  • co-occurring psychotic, bi-polar disorders, alcohol/substance dependence within the past six months
  • lack of capacity for consent
  • medical disorders that would affect weight and ability to participate
  • insufficient German language skills (assessment will be in German)
  • taking medication that would affect weight
  • irremovable metal attached to the body (e.g. piercings)
  • irremovable medical devices (e.g. pacemakers)
  • any trauma or surgery which may have left ferromagnetic material in the body
  • large tattoos
  • pregnancy
  • claustrophobia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Psychological Institute, University of Tübingen

Tübingen, Deutschland (deu), 72070, Germany

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

serum

MeSH Terms

Conditions

Binge-Eating Disorder

Interventions

Magnetic Resonance Imaging

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Intervention Hierarchy (Ancestors)

TomographyDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Nils B Kroemer, Dr

    University Hospital Tuebingen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 29, 2019

First Posted

December 4, 2019

Study Start

December 6, 2019

Primary Completion

May 31, 2021

Study Completion

May 31, 2021

Last Updated

August 11, 2021

Record last verified: 2021-04

Locations